These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8546390)

  • 1. Regulatory issues in the use of DNA vaccines.
    Minor PD
    Ann N Y Acad Sci; 1995 Nov; 772():170-7. PubMed ID: 8546390
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological properties of bacterial DNA.
    Pisetsky DS; Reich C; Crowley SD; Halpern MD
    Ann N Y Acad Sci; 1995 Nov; 772():152-63. PubMed ID: 8546388
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective efficacy of intramuscular immunization with naked DNA.
    Donnelly JJ; Ulmer JB; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():40-6. PubMed ID: 8546412
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunization against viral proteins with naked DNA.
    Ulmer JB; Donnelly JJ; Deck RR; DeWitt CM; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():117-25. PubMed ID: 8546384
    [No Abstract]   [Full Text] [Related]  

  • 5. Assuring the safety and efficacy of DNA vaccines.
    Griffiths E
    Ann N Y Acad Sci; 1995 Nov; 772():164-9. PubMed ID: 8546389
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk potential of the chromosomal insertion of foreign DNA.
    Kurth R
    Ann N Y Acad Sci; 1995 Nov; 772():140-51. PubMed ID: 8546386
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential DNA vaccine integration into host cell genome.
    Nichols WW; Ledwith BJ; Manam SV; Troilo PJ
    Ann N Y Acad Sci; 1995 Nov; 772():30-9. PubMed ID: 8546411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid malaria vaccines. Current status and potential.
    Hoffman SL; Doolan DL; Sedegah M; Gramzinski R; Wang H; Gowda K; Hobart P; Margalith M; Norman J; Hedstrom RC
    Ann N Y Acad Sci; 1995 Nov; 772():88-94. PubMed ID: 8546416
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
    Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid vaccination against virally induced tumors.
    Bright RK; Shearer MH; Kennedy RC
    Ann N Y Acad Sci; 1995 Nov; 772():241-51. PubMed ID: 8546399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA immunization with bovine herpesvirus-1 genes.
    Babiuk LA; Lewis PJ; Cox G; van Drunen Littel-van den Hurk S; Baca-Estrada M; Tikoo SK
    Ann N Y Acad Sci; 1995 Nov; 772():47-63. PubMed ID: 8546413
    [No Abstract]   [Full Text] [Related]  

  • 12. Retroviral vectors for HIV immunotherapy.
    Warner JF; Jolly D; Mento S; Galpin J; Haubrich R; Merritt J
    Ann N Y Acad Sci; 1995 Nov; 772():105-16. PubMed ID: 8546383
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination.
    Shiver JW; Perry HC; Davies ME; Freed DC; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():198-208. PubMed ID: 8546393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obtaining marketing authorization for nucleic acid vaccines in the European Union.
    Cichutek K
    Ann N Y Acad Sci; 1995 Nov; 772():178-85. PubMed ID: 8546391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization.
    Fuller JT; Fuller DH; McCabe D; Haynes JR; Widera G
    Ann N Y Acad Sci; 1995 Nov; 772():282-4. PubMed ID: 8546409
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
    Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
    J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization by direct DNA inoculation induces rejection of tumor cell challenge.
    Wang B; Merva M; Dang K; Ugen KE; Williams WV; Weiner DB
    Hum Gene Ther; 1995 Apr; 6(4):407-18. PubMed ID: 7612698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
    Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J
    J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant DNA virus vectors for vaccination.
    Moss B
    Semin Immunol; 1990 Sep; 2(5):317-27. PubMed ID: 2134016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.
    Zhai Y; Yang JC; Kawakami Y; Spiess P; Wadsworth SC; Cardoza LM; Couture LA; Smith AE; Rosenberg SA
    J Immunol; 1996 Jan; 156(2):700-10. PubMed ID: 8543823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.